The incidence of the side effect remains extremely rare, with only 833 cases reported worldwide from about 592 million administered doses of the adenovirus-based AstraZeneca vaccine, as of July 25.
The booster roll out in the UK is awaiting a green signal from the independent advisory body Joint Committee on Vaccination and Immunisation (JCVI), who are expecting study results on seven different booster vaccines.
"If an Indian citizen beneficiary has taken first dose of Covishield or AstraZeneca (ChAdOx1 nCov-19) vaccine outside India, the beneficiary can register on CoWIN app at the time of taking the second dose of Covishield vaccine after prescribed time interval and details of first dose can be recorded on the CoWIN app at the same time."
While the AstraZeneca vaccine produced in Europe, branded Vaxzevira, has been greenlighted by the European Medicines Agency (EMA), the Indian version Covishield has not even requested for market authorization.
Mixing doses could provide us with even greater flexibility for a booster programme, while also supporting countries who have further to go with their vaccine rollouts, and who may be experiencing supply difficulties.
London: A single dose of a Pfizer or AstraZeneca vaccine against coronavirus disease can reduce transmission by up to 50 per cent, finds a study. The study led by UK’s…
Washington: The Biden administration has came under intense pressure from various quarters, including the powerful US Chambers of Commerce, lawmakers and eminent Indian-Americans, to ship AstraZeneca and other COVID-19 vaccines…
Geneva: A causal link between the AstraZeneca Covid-19 vaccine and the rare occurrence of blood clots with low platelets is “considered plausible but not confirmed,” the World Health Organization (WHO)…
London: In the wake of several European countries suspending the use of the AstraZeneca Covid-19 vaccine, the company has said that there has been no evidence of increased blood clot risk from its jab. The suspensions have come amid several reports of blood clots following vaccinations with the Covid jab developed by the British-Swedish pharmaceutical […]
Geneva: Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization (WHO), said that the UN health agency “systematically reviews safety signals, and is carefully assessing the current reports on the AstraZeneca vaccine”. The Covid-19 vaccine developed by AstraZeneca and the University of Oxford has been suspended in a number of countries across Europe and Asia, […]
Kathmandu: Nepal on Sunday received the one million doses of Covishield vaccine it bought from India’s Serum Institute, in a major boost to the country’s fight against the COVID-19 pandemic. Oxford-AstraZeneca’s Covishield is being manufactured by Pune-based Serum Institute of India (SII) which has collaborated with Oxford University and pharmaceutical company AstraZeneca for making the […]
New Delhi: India has crossed a significant milestone in immunisation against Covid-19 with than 10 million people having been vaccinated, as of Friday, officials said. “In the fight against the global pandemic, as on February 19, till 8 a.m., the cumulative vaccine doses administered to healthcare and frontline workers against Covid-19 in the country have […]
London: The Oxford-AstraZeneca’s Covid-19 vaccine showed 76 per cent efficacy against symptomatic infection for three months after a single dose, with protection maintained to the second dose, the pharmaceutical company said on Wednesday. The primary analysis of the Phase 3 clinical trials, published as a preprint in The Lancet, also showed that with an inter-dose […]
New Delhi: Pune-based Serum Institute of India on Monday expressed hope at the possibility of Covid-19 vaccine – Covishield receiving the regulatory approval in “few days”, while emphasising that the company has a massive stockpile 40-50 million doses. The drug maker has partnered with global pharma giant AstraZeneca and the Oxford University for making the […]
New Delhi: Serum Institute of India, which has partnered with AstraZeneca to manufacture the Oxford-AstraZeneca vaccine, said on Saturday that the country would require a massive funding of Rs 80,000 crore for distribution of the Covid vaccine for the next one year. The Central government plans to vaccinate nearly 30 crore people in the first […]
London: The Oxford University and AstraZeneca COVID-19 vaccine is set to be used for a mix and match trial with Russia’s Sputnik vaccine against the novel coronavirus. The two sets of experts are to join forces to explore if a combination of the two jabs, both using a benign virus called adenovirus, could prove effective […]
New Delhi: After Sputnik V vaccines clinical trial’s preliminary results showed its efficacy at above 90 percent, the Russian Direct Investment Fund and Gamaleya Institute offered AstraZeneca the use of one of its two components in their own clinical trials. AstraZeneca accepted the proposal and will begin clinical trials of its vaccine in combination with […]
New Delhi: British-Swedish pharmaceutical firm AstraZeneca on Monday announced a partnership with Mumbai-based Qure.ai, a healthcare startup to integrate innovative artificial intelligence (AI) solutions for the early detection of lung cancer in patients across India. The partnership aims to harness and scale-up the use of this technology to improve early-stage detection of lung cancer in […]
New Delhi/Bhubaneswar: Of all the Covid vaccine candidates, who will be the first to achieve a near-complete efficacy is what everyone awaits now. On Monday, the university of Oxford achieved a significant milestone in the fight against Covid. Interim data shows the Oxford vaccine is 70.4 per cent effective, while tests on two dose regimens […]
London: Covid-19 vaccine developed by British-Swedish pharmaceutical firm AstraZeneca and Oxford University produced a strong immune response in older adults. The results have raised hopes that it can protect the age groups most at risk from the virus. The study, published in The Lancet medical journal, suggest that those aged over 70, who are at […]
Rio de Janeiro: Clinical trials of the Covid-19 vaccine being developed by British-Swedish pharmaceutical firm AstraZeneca and Oxford University will continue in Brazil despite the death of a volunteer, Brazilian health regulator Anvisa said recently. According to a report in The Wall Street Journal on Wednesday, Oxford University said it had carried out a careful […]
New Delhi: Clinical trials for the AstraZeneca Oxford coronavirus vaccine, AZD1222, have resumed in the UK following confirmation by the Medicines Health Regulatory Authority (MHRA) that it was safe to do so. On September 6, the standard review process had triggered a voluntary pause to vaccination across all global trials to allow review of safety […]
New York: Late-stage studies of AstraZeneca’s COVID-19 vaccine candidate are on temporary hold while the company investigates whether a recipient’s “potentially unexplained” illness is a side effect of the shot. In a statement issued on Tuesday evening, the company said its “standard review process triggered a pause to vaccination to allow review of safety data”. […]
Geneva: After admitting that the world may have a Covid-19 vaccine within one year or even a few months earlier, the World Health Organization (WHO) on Friday said that UK-based AstraZeneca is leading the vaccine race while US-based pharmaceutical major Moderan is not far behind. WHO Chief Scientist Soumya Swaminathan stated that the AstraZeneca’s coronavirus […]
London: AstraZeneca’s Covid-19 vaccine candidate developed by researchers from Oxford University will likely provide protection against the disease for one year, the British drug maker’s CEO told Belgian radio station Bel RTL on Tuesday. According to a report in City A.M., AstraZeneca is aiming to deliver two billion doses of the drug by the end […]